Agios Pharmaceuticals
Agios Pharmaceuticals is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
About Agios Pharmaceuticals
Agios Pharmaceuticals is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Agios Pharmaceuticals is a publicly traded biopharmaceutical company that discovers and develops novel therapies to treat cancer and rare genetic diseases by targeting cellular metabolism, with multiple approved oncology precision medicines and investigational therapies in clinical and preclinical stages.
Explore Agios Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.